Maria Aslani
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans.
Journal: Circulation
Published: October 07, 2024
The 129 strain-derived passenger mutations in ACKR1-deficient mice alter the expression of PYHIN and Fc-gamma receptor genes.
Journal: Journal of leukocyte biology
Published: July 31, 2024
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice.
Journal: Science translational medicine
Published: November 01, 2023
Targeting platelet-derived CXCL12 impedes arterial thrombosis.
Journal: Blood
Published: November 25, 2020
Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1.
Journal: Cell stem cell
Published: August 05, 2020
B-Cell-Specific CXCR4 Protects Against Atherosclerosis Development and Increases Plasma IgM Levels.
Journal: Circulation research
Published: February 21, 2020
Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development.
Journal: Thrombosis and haemostasis
Published: December 15, 2019
Transcriptome Analysis of Reticulated Platelets Reveals a Prothrombotic Profile.
Journal: Thrombosis and haemostasis
Published: September 02, 2019
Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis.
Journal: Science translational medicine
Published: August 22, 2019
Atypical Chemokine Receptors in Cardiovascular Disease.
Journal: Thrombosis and haemostasis
Published: February 05, 2019
PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function.
Journal: Science immunology
Published: November 08, 2017
Last Updated: 09/26/2026